- Home
- GAIN vs LXEO Comparison
GAIN vs LXEO Comparison
Compare GAIN & LXEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Company Overview
Basic Information| Metric | GAIN | LXEO |
|---|---|---|
| Founded | 2005 | 2017 |
| Country | United States | United States |
| Employees | 70 | 75 |
| Industry | Finance: Consumer Services | |
| Sector | Finance | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 558.3M | 486.1M |
| IPO Year | N/A | 2023 |
Fundamental Metrics
Financial Performance| Metric | GAIN | LXEO |
|---|---|---|
| Price | $13.97 | $6.57 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 10 |
| Target Price | $14.75 | ★ $18.60 |
| AVG Volume (30 Days) | 279.2K | ★ 705.5K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | ★ 10.70% | N/A |
| EPS Growth | N/A | ★ 75.08 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $654,000.00 |
| Revenue This Year | $5.67 | N/A |
| Revenue Next Year | $6.44 | N/A |
| P/E Ratio | $4.38 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $11.42 | $1.45 |
| 52 Week High | $15.25 | $10.99 |
Technical Indicators
Market Signals| Indicator | GAIN | LXEO |
|---|---|---|
| Relative Strength Index (RSI) | 56.72 | 41.71 |
| Support Level | $13.69 | $6.15 |
| Resistance Level | $14.17 | $7.77 |
| Average True Range (ATR) | 0.34 | 0.50 |
| MACD | 0.03 | 0.02 |
| Stochastic Oscillator | 66.79 | 14.02 |
Price Performance
Historical ComparisonAbout GAIN Gladstone Investment Corporation Business Development Company
Gladstone Investment Corp operates as an externally managed, closed-end, non-diversified management investment company. Its objective is to invest in debt and equity securities of established private businesses operating in the U.S. and to achieve and grow current income by investing in debt securities of established businesses; provide the stockholders with long-term capital appreciation in the value of its assets by investing in equity securities of established businesses. It focuses on investing in lower-middle-market private businesses.
About LXEO Lexeo Therapeutics Inc.
Lexeo Therapeutics Inc is a clinical-stage genetic medicines company committed to transforming healthcare by applying pioneering science to fundamentally alter how diseases are treated. The company focuses on preclinical and clinical stage gene therapies, specifically hereditary and acquired diseases with high unmet needs, which represent its sole business segment.